The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Open accessAbstract
New blood vessel formation (angiogenesis) is fundamental to tumor growth, invasion, and metastatic dissemination. The vascular endothelial growth factor (VEGF) signaling pathway plays pivotal roles in regulating tumor angiogenesis. VEGF as a therapeutic target has been validated in various types of human cancers. Different agents including antibodies, aptamers, peptides, and small molecules have been extensively investigated to block VEGF and its pro-angiogenic functions. Some of these agents have been approved by FDA and some are currently in clinical trials. Combination therapies are also being pursued for better tumor control. By providing comprehensive real-time information, molecular imaging of VEGF pathway may accelerate the drug development process. Moreover, the imaging will be of great help for patient stratification and therapeutic effect monitoring, which will promote effective personalized molecular cancer therapy. This review summarizes the current status of tumor therapeutic agents targeting to VEGF and the applications of VEGF related molecular imaging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–215 of 215
Hughes, M. S., Marsh, J. N., Zhang, H., Woodson, A. K., Allen, J. S., Lacy, E. K., Carradine, C., Lanza, G., & Wickline, S. A. (2006) · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control · doi:10.1109/tuffc.2006.1678189 · Cited by 50
Contrast-Enhanced Computed Tomography and Ultrasound for the Evaluation of Tumor Blood Flow
Broumas, A. R., Pollard, R. E., Bloch, S. H., Wisner, E. R., Griffey, S. M., & Ferrara, K. W. (2005) · Investigative Radiology · doi:10.1097/01.rli.0000152833.35744.7f · Cited by 48
Wang, Y., Iyer, M. R., Annala, A. J., Wu, L., Carey, M., & Gambhir, S. S. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00308.2004 · Cited by 46
Morimoto, A. M., Tan, N., West, K. A., McArthur, G. A., Toner, G. C., Manning, W. C., Smolich, B. D., & Cherrington, J. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207268 · Cited by 46
Improving delivery of antineoplastic agents with anti‐vascular endothelial growth factor therapy
Yang, A. D., Bauer, T. W., Camp, E. R., Somcio, R., Liu, W., Fan, F., & Ellis, L. M. (2005) · Cancer · doi:10.1002/cncr.20942 · Cited by 42
Watanabe, H., Mamelak, A. J., Wang, B., Howell, B. G., Freed, I., Esche, C., Nakayama, M., Nagasaki, G., Hicklin, D. J., Kerbel, R. S., et al. (2004) · Experimental Dermatology · doi:10.1111/j.0906-6705.2004.00240.x · Cited by 42
Hasskarl, J. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-01222-8_5 · Cited by 41
Self-Assembled “Dock and Lock” System for Linking Payloads to Targeting Proteins
Backer, M. V., Patel, V., Jehning, B. T., & Backer, J. M. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060037u · Cited by 37
Zwolak, P., Jasiński, P., Terai, K., Gallus, N. J., Ericson, M. E., Clohisy, D. R., & Dudek, A. Z. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.07.011 · Cited by 36
Gamble, J. R., Meyer, G. T., Noack, L., Furze, J., Matthias, L. J., Kovach, N., Harlan, J., & Vadas, M. A. (1999) · Endothelium · doi:10.3109/10623329909165309 · Cited by 35
Miller, K. D., Soule, S. E., Calley, C. S. J., Emerson, R. E., Hutchins, G. D., Kopecky, K. K., Badve, S., Storniolo, A. M., Goulet, R. J., & Sledge, G. W. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-2044-y · Cited by 35
Chen, Y., Hong, T.-M., Tsai, S.-H., & Tsai, I. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-09-0568 · Cited by 25
Izzo, A. D., Mackanos, M. A., Beckham, J. T., & Jansen, D. (2001) · Lasers in Surgery and Medicine · doi:10.1002/lsm.1127 · Cited by 21
Combined anti-proliferative and anti-angiogenic strategies for cancer
Bar, J., & Onn, A. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.5.701 · Cited by 19
松本, 和., & 西尾, 和. (2006) · Mebio oncology · Cited by 1
Cited by
Cell death-based treatment of lung adenocarcinoma
Denisenko, T. V., Budkevich, I. N., & Zhivotovsky, B. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0063-y · Cited by 768
Regulatory mechanisms of PD-1/PD-L1 in cancers
Lin, X., Kang, K., Chen, P., Zeng, Z., Li, G., Xiong, W., Yi, M., & Xiang, B. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02023-w · Cited by 784
Tumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
A snapshot of the PD-1/PD-L1 pathway
Ghosh, C., Luong, G., & Sun, Y. (2021) · Journal of Cancer · doi:10.7150/jca.57334 · Cited by 292
Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases
Fallah, A., Sadeghinia, A., Kahroba, H., Samadi, A., Heidari, H. R., Bradaran, B., Zeinali, S., & Molavi, O. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.022 · Cited by 259
Metadata
- Authors
- Niu, G., & Chen, X.
- Venue
- Current Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-08-01
- Volume
- 11
- Issue
- 8
- Pages
- 1000-1017
- ISSN
- 1389-4501 (ISSN-L)
- OpenAlex
- W2055242813
- Cited by
- 451
- References
- 215
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.